Chauhan D - Search Results

1

2-Methoxyestardiol and bortezomib/proteasome-inhibitor overcome dexamethasone-resistance in multiple myeloma cells by modulating Heat Shock Protein-27.

Chauhan D, Li G, Auclair D, Hideshima T, Podar K, Mitsiades N, Mitsiades C, Chen LB, Munshi N, Saxena S, Anderson KC. Chauhan D, et al. Apoptosis. 2004 Mar;9(2):149-55. doi: 10.1023/B:APPT.0000018797.66067.6c. Apoptosis. 2004. PMID: 15004512

2

The proteasome inhibitor PS-341 inhibits growth, induces apoptosis, and overcomes drug resistance in human multiple myeloma cells.

Hideshima T, Richardson P, Chauhan D, Palombella VJ, Elliott PJ, Adams J, Anderson KC. Hideshima T, et al. Among authors: chauhan d. Cancer Res. 2001 Apr 1;61(7):3071-6. Cancer Res. 2001. PMID: 11306489

3

Apoptosis in multiple myeloma: therapeutic implications.

Chauhan D, Anderson KC. Chauhan D, et al. Apoptosis. 2001 Feb-Apr;6(1-2):47-55. doi: 10.1023/a:1009620027205. Apoptosis. 2001. PMID: 11321040 Review.

4

Novel therapies targeting the myeloma cell and its bone marrow microenvironment.

Hideshima T, Chauhan D, Podar K, Schlossman RL, Richardson P, Anderson KC. Hideshima T, et al. Among authors: chauhan d. Semin Oncol. 2001 Dec;28(6):607-12. doi: 10.1016/s0093-7754(01)90033-8. Semin Oncol. 2001. PMID: 11740818 Review.

5

Mechanisms of cell death and survival in multiple myeloma (MM): Therapeutic implications.

Chauhan D, Anderson KC. Chauhan D, et al. Apoptosis. 2003 Aug;8(4):337-43. doi: 10.1023/a:1024164700094. Apoptosis. 2003. PMID: 12815276 Review.

6

A novel Bcl-2/Bcl-X(L)/Bcl-w inhibitor ABT-737 as therapy in multiple myeloma.

Chauhan D, Velankar M, Brahmandam M, Hideshima T, Podar K, Richardson P, Schlossman R, Ghobrial I, Raje N, Munshi N, Anderson KC. Chauhan D, et al. Oncogene. 2007 Apr 5;26(16):2374-80. doi: 10.1038/sj.onc.1210028. Epub 2006 Oct 2. Oncogene. 2007. PMID: 17016430

7

A novel proteasome inhibitor NPI-0052 as an anticancer therapy.

Chauhan D, Hideshima T, Anderson KC. Chauhan D, et al. Br J Cancer. 2006 Oct 23;95(8):961-5. doi: 10.1038/sj.bjc.6603406. Br J Cancer. 2006. PMID: 17047643 Free PMC article. Review.

8

A pivotal role for Mcl-1 in Bortezomib-induced apoptosis.

Podar K, Gouill SL, Zhang J, Opferman JT, Zorn E, Tai YT, Hideshima T, Amiot M, Chauhan D, Harousseau JL, Anderson KC. Podar K, et al. Among authors: chauhan d. Oncogene. 2008 Jan 31;27(6):721-31. doi: 10.1038/sj.onc.1210679. Epub 2007 Jul 23. Oncogene. 2008. PMID: 17653083

9

Bone marrow microenvironment and the identification of new targets for myeloma therapy.

Podar K, Chauhan D, Anderson KC. Podar K, et al. Among authors: chauhan d. Leukemia. 2009 Jan;23(1):10-24. doi: 10.1038/leu.2008.259. Epub 2008 Oct 9. Leukemia. 2009. PMID: 18843284 Free PMC article. Review.

10

Preclinical activity of P276-00, a novel small-molecule cyclin-dependent kinase inhibitor in the therapy of multiple myeloma.

Raje N, Hideshima T, Mukherjee S, Raab M, Vallet S, Chhetri S, Cirstea D, Pozzi S, Mitsiades C, Rooney M, Kiziltepe T, Podar K, Okawa Y, Ikeda H, Carrasco R, Richardson PG, Chauhan D, Munshi NC, Sharma S, Parikh H, Chabner B, Scadden D, Anderson KC. Raje N, et al. Among authors: chauhan d. Leukemia. 2009 May;23(5):961-70. doi: 10.1038/leu.2008.378. Epub 2009 Jan 8. Leukemia. 2009. PMID: 19151776

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

958 results

Search Page

Filters